Manchester Tech Trust Angels

Molymem is a company dedicated to improving the efficiency of filtering membranes utilized in separation processes, particularly in desalination and the removal of industrial contaminants. The firm develops functional and sustainable membrane technology that addresses global water and wastewater challenges. Its innovative membranes are designed to achieve high water permeance, selective species rejection, and corrosion resistance. This technology enables industries and municipalities to reduce their environmental impact while managing water resources more effectively.

Biorelate Ltd., founded by Daniel Jamison in 2014, is a biomedical research company based in Oldham, United Kingdom. The company specializes in providing services for the development of biomarkers aimed at diagnosing prostate cancer, validating targets, and advancing new drug development. Biorelate's platform curates biomedical knowledge to support innovations in biotechnological research, offering functions such as auto-curating valuable data from various text sources and automatically ingesting information to identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This enables scientists to conduct more efficient research in drug discovery, cancer diagnosis, and target validation.

Biorelate Ltd., founded by Daniel Jamison in 2014, is a biomedical research company based in Oldham, United Kingdom. The company specializes in providing services for the development of biomarkers aimed at diagnosing prostate cancer, validating targets, and advancing new drug development. Biorelate's platform curates biomedical knowledge to support innovations in biotechnological research, offering functions such as auto-curating valuable data from various text sources and automatically ingesting information to identify causal interactions between genes, chemicals, drugs, cells, and phenotypes. This enables scientists to conduct more efficient research in drug discovery, cancer diagnosis, and target validation.